Parthenon Capital Invests in RxSense

We served as healthcare regulatory counsel to Parthenon Capital, a growth-oriented private equity firm, in its investment in RxSense, a high-growth healthcare technology company that utilizes its proprietary technology platform to provide innovative prescription savings solutions to consumers and pharmacy benefits administration and analytics to enterprise customers. Terms of the transaction were not disclosed.

You Also May Be Interested In:

  • We successfully defended a national home healthcare provider in appealing an $18 million extrapolated overpayment resulting from a UPIC audit.

    We successfully defended a national home healthcare provider in appealing an $18 million extrapolated overpayment resulting from a UPIC audit....
    Client Type: Public Company
  • Representation of Pharos Capital’s post-acute care provider platform, Charter Health Care Group, in its acquisition of Genesis Hospice, a Texas-based hospice care provider. The addition of Genesis and Saints brings the number of Charter locations to 18 and marks the company’s fourth program in Texas.

    We represented Pharos Capital’s post-acute care provider platform, Charter Health Care Group, in its acquisition of Genesis Hospice, a Texas-based...
  • Representation of Addus HomeCare Corporation (NASDAQ: ADUS) in its $29.1 million acquisition of three affiliated entities: Armada Skilled Home Care of New Mexico, LLC, Armada Hospice of New Mexico, LLC and Armada Hospice of Santa Fe, LLC. This acquisition expands Addus HomeCare’s home health and hospice services in the state of New Mexico.

    We represented Addus HomeCare Corporation (NASDAQ: ADUS) in its $29.1 million acquisition of three affiliated entities: Armada Skilled Home Care...
    Client Type: Public Company